VA
UPB

Verdad Advisers’s Upstream Bio Inc UPB Stock Holding History

Verdad Advisers’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+21,810
New +$183K 0.14% 165

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verdad Advisers's UPB Position: Q2 2026 in Review

Verdad Advisers opened a new position in Upstream Bio Inc (UPB) in Q2 2026: 21,810 shares worth $151K. The stake represents 0.14% of the portfolio and ranks #165 among its holdings.

150 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • Verdad Advisers held 21,810 shares of Upstream Bio Inc worth $151K as of Q2 2026.
  • Upstream Bio Inc was a new Verdad Advisers position in Q2 2026.
  • Upstream Bio Inc made up 0.14% of Verdad Advisers's portfolio in Q2 2026, its #165 holding.
  • 150 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.